BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

639 related articles for article (PubMed ID: 23345372)

  • 1. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation.
    Atwell TD; Schmit GD; Boorjian SA; Mandrekar J; Kurup AN; Weisbrod AJ; Chow GK; Leibovich BC; Callstrom MR; Patterson DE; Lohse CM; Thompson RH
    AJR Am J Roentgenol; 2013 Feb; 200(2):461-6. PubMed ID: 23345372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous cryoablation of anterior renal masses: technique, efficacy, and safety.
    Schmit GD; Atwell TD; Leibovich BC; Callstrom MR; Kurup AN; Woodrum DA; Charboneau JW
    AJR Am J Roentgenol; 2010 Dec; 195(6):1418-22. PubMed ID: 21098204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.
    Tracy CR; Raman JD; Donnally C; Trimmer CK; Cadeddu JA
    Cancer; 2010 Jul; 116(13):3135-42. PubMed ID: 20564644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of percutaneous and laparoscopic cryoablation for the treatment of solid renal masses.
    Hinshaw JL; Shadid AM; Nakada SY; Hedican SP; Winter TC; Lee FT
    AJR Am J Roentgenol; 2008 Oct; 191(4):1159-68. PubMed ID: 18806159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation.
    Hegarty NJ; Gill IS; Desai MM; Remer EM; O'Malley CM; Kaouk JH
    Urology; 2006 Jul; 68(1 Suppl):7-13. PubMed ID: 16857454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
    Moynagh MR; Schmit GD; Thompson RH; Boorjian SA; Woodrum DA; Curry TB; Atwell TD
    J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation of renal tumors in the solitary kidney.
    Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE
    Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
    Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures.
    Atwell TD; Carter RE; Schmit GD; Carr CM; Boorjian SA; Curry TB; Thompson RH; Kurup AN; Weisbrod AJ; Chow GK; Leibovich BC; Callstrom MR; Patterson DE
    J Vasc Interv Radiol; 2012 Jan; 23(1):48-54. PubMed ID: 22037491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
    Forauer AR; Dewey BJ; Seigne JD
    Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients.
    Schmit GD; Atwell TD; Callstrom MR; Farrell MA; Leibovich BC; Patterson DE; Chow GK; Blute ML; Charboneau JW
    J Endourol; 2010 Aug; 24(8):1255-62. PubMed ID: 20380510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliation of painful metastatic disease involving bone with imaging-guided treatment: comparison of patients' immediate response to radiofrequency ablation and cryoablation.
    Thacker PG; Callstrom MR; Curry TB; Mandrekar JN; Atwell TD; Goetz MP; Rubin J
    AJR Am J Roentgenol; 2011 Aug; 197(2):510-5. PubMed ID: 21785102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomes.
    Raman JD; Thomas J; Lucas SM; Bensalah K; Lotan Y; Trimmer C; Cadeddu JA
    Can J Urol; 2008 Apr; 15(2):3980-5. PubMed ID: 18405445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
    Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
    J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
    Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous renal cryoablation: local control at mean 26 months of followup.
    Atwell TD; Callstrom MR; Farrell MA; Schmit GD; Woodrum DA; Leibovich BC; Chow GK; Patterson DE; Blute ML; Charboneau JW
    J Urol; 2010 Oct; 184(4):1291-5. PubMed ID: 20719341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential combination treatment (arterial embolization and percutaneous radiofrequency ablation) of inoperable renal cell carcinoma: single-center pilot study.
    Nakasone Y; Kawanaka K; Ikeda O; Tamura Y; Yamashita Y
    Acta Radiol; 2012 May; 53(4):410-4. PubMed ID: 22393159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.